Necrotizing sarcoid granulomatosis (NSG) is a rare entity mainly characterized by a prominent granulomatous vasculitis affecting middle-aged or old individuals and with a favorable prognosis. Although many believe it is a variant of sarcoidosis, the proper classification is still a matter of debate as some of its features are found in sarcoidosis but also in Churg-Strauss syndrome, Wegener’s disease and hypersensitivity pneumonitis. In this paper, we described for the first time a case of NSG in a family with several cases of sarcoidosis, reinforcing the relationship between NSG and sarcoidosis. Additional interesting findings were the young age of the patient (15 years old), the symptoms limited to the respiratory tract (uncommon when NSG affects youngsters) and the increase in serologic markers of autoimmune disease. Though complete criteria for autoimmune disease were not present, systemic lupus erythematosus and Sjögren’s syndrome are possible candidates. As sarcoidosis is described to be associated with several autoimmune diseases, this finding is an additional suggestion of the relationship between both entities.

Keywords:
Necrotizing sarcoid granulomatosis, Sarcoidosis, Granulomatous vasculitis
1.
Liebow AA: Pulmonary angiitis and granulomatosis. Am J Respir Dis 1973;108:1–18.
2.
Singh N, Cole S, Krause PJ, Conway M, Garcia L: Necrotizing sarcoid granulomatosis with extrapulmonary involvement. Clinical, pathologic, ultrastructural, and immunologic features. Am Rev Respir Dis 1981;124:189–192.
3.
Churg A, Carrington CB, Gupta R: Necrotizing sarcoid granulomatosis. Chest 1979;76:406–413.
4.
Cuadra Llopart L, Barreiro Lopez B, Forcada Guiu P: Necrotizing sarcoid granulomatosis. Arch Bronconeumol 2005;41:355–356.
5.
Harada T, Amano T, Takahashi A, Furuya J, Yamaguchi E, Kaji M, Morikawa T, Itoh T, Shimizu M, Nishimura M: Necrotizing sarcoid granulomatosis presenting with elevated serum soluble interleukin-2 receptor levels. Respiration 2002;69:468–470.
6.
Robaday S, Herve F, Cailleux N, Dominique S, Levesque H, Marie I: Association of sarcoidosis and Takayasu’s arteritis: an additional case report. Rev Med Interne 2005;10:816–819.
7.
Liozon E, Loustaud-Ratti V, Soria P, Bezanahary H, Fauchais AL, Nadalon S, Rhaiem K, Ly K, Vidal E: Disease associations in 250 patients with temporal (giant cell) arteritis. Presse Med 2004;33:1304–1312.
8.
Didier A, Legrand MF, Arlet-Suau E, Leophonte P: Sarcoidosis and autoimmunity. Apropos of 2 cases. Rev Pneumol Clin 1988;44:74–77.
9.
Morgan R, Hall GH: Auto-immune thyroiditis and thyroid lymphoma arising in a patient with sarcoidosis. Br J Clin Pract 1987;41:629–630.
10.
Lois M, Roman J, Holland W, Agudelo C: Coexisting Sjögren’s syndrome and sarcoidosis in the lung. Semin Arthritis Rheum 1998;28:31–40.
11.
Ramos-Casals M, Brito-Zeron P, Garcia-Carrasco M, Font J: Sarcoidosis or Sjögren’s syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine 2004;83:85–95.
12.
Deheinzelin D, de Carvalho CR, Tomazini ME, Barbas Filho JV, Saldiva PH: Association of Sjögren’s syndrome and sarcoidosis. Report of a case. Sarcoidosis 1988;5:68–70.
13.
Radenne F, Tillie-Leblond I, Maurage CA, Remy-Jardin M, Wallaert B, Tonnel AB: Sjögren’s syndrome and necrotizing sarcoid-like granulomatosis. Rev Mal Respir 1999;16:554–557.
14.
Heinrich D, Gordjani N, Trusen A, Marx A, Hebestreit H: Necrotizing sarcoid granulomatosis: a rarity in childhood. Pediatr Pulmonol 2003;35:407–411.
15.
Strickland-Marmol LB, Fessler RG, Rojiani AM: Necrotizing sarcoid granulomatosis mimicking an intracranial neoplasm: clinicopathologic features and review of the literature. Mod Pathol 2000;13:909–913.
16.
Brevet F, Hachulla E, Courtin P, Gosselin B, Wurtz A, Hatron PY, Devulder B: Systemic form of sarcoid-like necrotizing granulomatosis with ocular, pulmonary and cerebral involvement. Rev Med Interne 1993;14:243–248.
17.
Lee SC, Spencer J, Rumberg J, Dickson DW: Isolated central nervous system granulomatosis resembling sarcoidosis. J Neurol 1989;236:356–358.
18.
Beach RC, Corrin B, Scopes JW, Graham E: Necrotizing sarcoid granulomatosis with neurologic lesions in a child. J Pediatr 1980;97:950–953.
19.
Koss MN, Moon S, Hochholzer L, Feigin DS, et al: Necrotizing sarcoid-like granulomatosis: clinical, pathologic and immunopathologic findings. Hum Pathol 1980;11:510.
20.
Tauber E, Wojnarowski C, Horcher E, Dekan G, Frischer T: Necrotizing sarcoid granulomatosis in a 14-yr-old female. Eur Respir J 1999;13:703–705.
21.
Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG), adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736–755.
22.
Costabel U: Sarcoidosis: clinical update. Eur Respir J 2001;32(suppl):56s–68s.
23.
Newman LS, Rose CS, Maier LA: Sarcoidosis. N Engl J Med 1997;336:1224–1234 (erratum published in N Engl J Med 1997;337:139).
24.
Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J Jr, Chase GA, Iannuzzi MC: Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001;153:188–193.
25.
Schürmann M, Lympany PA, Reichel P, Müller-Myhsok B, Wurm K, Schlaak M, Müller-Quernheim J, Du Bois RM, Schwinger E: Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000;162:861–864.
26.
Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, Terrin ML, Moller DR, Barnard J, et al: ACCESS Research Group. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001;164:2085–2091.
27.
Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA: Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003;167:1225–1231.
28.
Schurmann M, Lympany PA, Reichel P, Müller-Myhsok B, Wurm K, Schlaak M, Müller-Quernheim J, du Bois RM, Schwinger E: Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000;162:861–864.
29.
Schurmann M, Reichel P, Müller-Myhsok B, Schlaak M, Müller-Quernheim J, Schwinger E: Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001;164:840–846.
30.
Gross BH, Scheider HJ, Proto AV: Eggshell calcification of lymph nodes: an update. Am J Roentgenol 1980;135:1265.
31.
Shulimzon T, Rozenman J, Perelman M, Bardan E, Ben-Dov I: Necrotizing granulomata in the lung preceding colonic involvement in 2 patients with Crohn’s disease. Respiration 2007;74:698–702.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.